Society guideline links: Perioperative management of patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs)

Introduction —

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Preoperative medical evaluation and risk assessment".)

●(See "Society guideline links: Preoperative fasting".)

●(See "Society guideline links: Airway management in adults".)

●(See "Society guideline links: Obesity in adults".)

●(See "Society guideline links: Diabetes mellitus in adults".)

International

●American Gastroenterological Association (AGA), American Society for Metabolic and Bariatric Surgery (ASMBS), American Society of Anesthesiologists (ASA), International Society of Perioperative Care of Patients with Obesity (ISPCOP), and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES): Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period (2024)

Canada

●Canadian Anesthesiologists' Society (CAS): Medication safety bulletin – Semaglutide (2023)

United States

●American Gastroenterological Association (AGA): Rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy – Communication (2024)